Similar Papers

Paper Title
Journal
Date
Author
First-line and maintenance treatment with rituximab for patients with indolent non-Hodgkin's lymphoma
John D Hainsworth
Seminars in Oncology | VOL. 30
John D HainsworthJohn D Hainsworth
01 Feb 2003
Highlights From: 43rd Annual Meeting of the American Society of Hematology December 7–11, 2001 Orlando, Florida: First International Congress on Monoclonal Antibodies in Cancer August 30-September 2, 2001 Banff, Alberta, Canada
Amy I D'Orazio ... Vinay K Jain
Clinical Lymphoma | VOL. 2
Amy I D'Orazio, et. al.Amy I D'Orazio ... Vinay K Jain
01 Dec 2001
Rituximab as first-line and maintenance therapy for patients with indolent non-Hodgkin's lymphoma: Interim follow-up of a multicenter phase II trial
John D Hainsworth
Seminars in Oncology | VOL. 29
John D HainsworthJohn D Hainsworth
01 Feb 2002
Fludarabine, Cyclophosphamide, Rituximab (FCR) and Vorinostat Followed By Rituximab and Vorinostat Maintenance Therapy in Patients with Previously Untreated Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL) - Final Results of a Phase I/II Study
Mazyar Shadman ... John M Pagel
Blood | VOL. 128
Mazyar Shadman, et. al.Mazyar Shadman ... John M Pagel
02 Dec 2016
View more papers

More From: The hematology journal : the official journal of the European Haematology Association

Paper Title
Journal
Date
Author
Expression and activation of SHC/MAP kinase pathway in primary acute myeloid leukemia blasts.
...
The hematology journal : the official journal of the European Haematology Association | VOL. 2
, et. al. ...
22 Mar 2016
Risk-oriented postremission strategies in adult acute lymphoblastic leukemia: prospective confirmation of anthracycline activity in standard-risk class and role of hematopoietic stem cell transplants in high-risk groups.
R Bassan ... T Barbui
The hematology journal : the official journal of the European Haematology Association | VOL. 2
R Bassan, et. al.R Bassan ... T Barbui
18 Mar 2016
Repeated rituximab maintenance courses in fludarabine-failed young patients with chronic lymphocytic leukaemia responding to FAND chemotherapy.
Laura Scaramucci ... Velia Bongarzoni
The hematology journal : the official journal of the European Haematology Association | VOL. 5
Laura Scaramucci, et. al.Laura Scaramucci ... Velia Bongarzoni
01 Jan 2004
Characterisation of TP53 abnormalities in chronic lymphocytic leukaemia.
Patrick D Thornton ... Daniel Catovsky
The hematology journal : the official journal of the European Haematology Association | VOL. 5
Patrick D Thornton, et. al.Patrick D Thornton ... Daniel Catovsky
01 Jan 2004
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.